-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, J7MMJVjhfrc3XTD69Fvi4D8UsPGWGzCxHWfTdn7/zxF7s7S7l/UROnoTB2a87Yog nOqiG2K/cdgZLCcnR6IlWw== 0001144204-09-047507.txt : 20090908 0001144204-09-047507.hdr.sgml : 20090907 20090908164754 ACCESSION NUMBER: 0001144204-09-047507 CONFORMED SUBMISSION TYPE: F-X PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20090908 DATE AS OF CHANGE: 20090908 EFFECTIVENESS DATE: 20090908 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: YM BIOSCIENCES INC CENTRAL INDEX KEY: 0001178347 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: F-X SEC ACT: 1933 Act SEC FILE NUMBER: 333-161786 FILM NUMBER: 091058483 BUSINESS ADDRESS: STREET 1: 5045 ORBITOR DRIVE STREET 2: BUILDING 11 SUITE 400 CITY: MISSISSAUGA STATE: A6 ZIP: 00000 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: YM BIOSCIENCES INC CENTRAL INDEX KEY: 0001178347 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: F-X BUSINESS ADDRESS: STREET 1: 5045 ORBITOR DRIVE STREET 2: BUILDING 11 SUITE 400 CITY: MISSISSAUGA STATE: A6 ZIP: 00000 F-X 1 v159885_fx.htm Unassociated Document
 
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549
_________________________
 
FORM F-X
 
APPOINTMENT OF AGENT FOR SERVICE OF
PROCESS AND UNDERTAKING
_________________________
 
A.           Name of issuer or person filing (“Filer”):  YM BioSciences Inc.
 
B. 
(1)          This is (check one):
 
x
An original filing for the Filer.
 
¨
An amended filing for the Filer.
 
 
(2)
Check the following box if you are filing the Form F-X in paper in accordance with Regulation S-T Rule 101(b)(9) ¨
 
C.           Identify the filing in conjunction with which this form is being filed:
 
Name of registrant:
YM BioSciences Inc.
Form type:
Form F-10
File number (if known):
333-161786
Filed by:
YM BioSciences Inc.
Date filed (if filed concurrently, so indicate):
September 8, 2009 (filed concurrently)
 
D.
The Filer is incorporated or organized under the laws of Nova Scotia, Canada, and has its principal place of business at Suite 400, Building 11, 5045 Orbitor Drive, Mississauga, Ontario, Canada  L4W 4Y4; telephone (905) 629-9761.
 
E.
Filer designates and appoints YM BioSciences USA Inc. (“Agent”), located at 701 Lee Road, Suite 200, Wayne, Pennsylvania  19087; telephone (610) 560-0600 as the agent of the Filer upon whom may be served any process, pleadings, subpoenas, or other papers in:
 
 
(a)
any investigation or administrative proceeding conducted by the Commission; and
 
 
(b)
any civil suit or action brought against the Filer or to which the Filer has been joined as defendant or respondent, in any appropriate court in any place subject to the jurisdiction of any state or of the United States, or of any of its territories or possessions or of the District of Columbia, where the investigation, proceeding or cause of action arises out of or relates to or concerns any offering made or purported to be made in connection with the securities registered or qualified by the Filer on Form F-10 on September 8, 2009 or any purchases or sales of any security in connection therewith.  The Filer stipulates and agrees that any such civil suit or action or administrative proceeding may be commenced by the service of process upon, and that the service of an administrative subpoena shall be effected by service upon such agent for service of process, and that the service as aforesaid shall be taken and held in all courts and administrative tribunals to be valid and binding as if personal service thereof had been made.
 
F.
The Filer stipulates and agrees to appoint a successor agent for service of process and file an amended Form F-X if the Filer discharges the Agent or the Agent is unwilling or unable to accept service on behalf of the Filer at any time until six years have elapsed from the date the issuer of the securities to which the Form F-10 relates has ceased reporting under the Exchange Act.
 
 
The Filer further undertakes to advise the Commission promptly of any change to the Agent’s name or address during the applicable period by amendment of this form, referencing the file number of the relevant form in conjunction with which the amendment is being filed.
 
G.
The Filer undertakes to make available, in person or by telephone, representatives to respond to inquiries made by the Commission staff, and to furnish promptly, when requested to do so by the Commission staff, information relating to: the Form F-10; the securities to which the Form F-10 relates; and the transactions in such securities.
 
 
 
 

SIGNATURES
 
The Filer certifies that it has duly caused this power of attorney, consent, stipulation and agreement to be signed on its behalf by the undersigned, thereunto duly authorized, in Mississauga, Ontario, Canada, on September 8, 2009.
 
YM BIOSCIENCES INC.
   
By:
/s/ David G. P. Allan
 
David G. P. Allan
 
President & Chief Executive Officer
 
This statement has been signed by the following person in the capacity indicated on September 8, 2009.
 
YM BIOSCIENCES USA INC.
as Agent for Service of Process for YM BioSciences Inc.
   
By:
/s/ David G. P. Allan
 
David G. P. Allan
 
President
 
 
 
 

-----END PRIVACY-ENHANCED MESSAGE-----